ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 208 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,318,000 | +13.7% | 45,695 | +25.4% | 0.00% | +100.0% |
Q3 2016 | $1,159,000 | +1.0% | 36,436 | +3.0% | 0.00% | 0.0% |
Q2 2016 | $1,148,000 | -86.0% | 35,369 | -88.0% | 0.00% | -90.9% |
Q1 2016 | $8,219,000 | -18.2% | 293,964 | +4.3% | 0.01% | -15.4% |
Q4 2015 | $10,048,000 | +8.4% | 281,840 | +0.5% | 0.01% | 0.0% |
Q3 2015 | $9,270,000 | -22.0% | 280,325 | -1.2% | 0.01% | -13.3% |
Q2 2015 | $11,881,000 | +65.9% | 283,682 | +29.1% | 0.02% | +66.7% |
Q1 2015 | $7,160,000 | +4.1% | 219,708 | +1.4% | 0.01% | 0.0% |
Q4 2014 | $6,881,000 | +27.2% | 216,723 | -0.8% | 0.01% | +12.5% |
Q3 2014 | $5,410,000 | -2.9% | 218,506 | -11.4% | 0.01% | +14.3% |
Q2 2014 | $5,572,000 | +6.1% | 246,650 | +14.3% | 0.01% | -12.5% |
Q1 2014 | $5,251,000 | +7.7% | 215,810 | +10.6% | 0.01% | +14.3% |
Q4 2013 | $4,875,000 | -11.3% | 195,083 | -2.5% | 0.01% | -22.2% |
Q3 2013 | $5,496,000 | +60.7% | 200,075 | +6.1% | 0.01% | +50.0% |
Q2 2013 | $3,421,000 | – | 188,486 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |